Stephen L. Lowe

4.2k citations
77 papers · 2.8k · 1 hit paper · h-index 23

Impact in

Papers in

Stephen L. Lowe

76 papers receiving 2.7k citations

Stephen L. Lowe's Hit Papers

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial 2007 · 793 citations
7930+6+12Years since publication250500750

Peers

Stephen L. Lowe
Comparison fields: 5 of 109
  • Biological Psychiatry 221
  • Cellular and Molecular Neuroscience 1.2k
  • Physiology 650
  • Psychiatry and Mental health 348
  • Pharmacology 378
Replace Edilio Borroni with:
Edilio Borroni Switzerland
Ernesto Fedele Italy
Robert E. Davis United States
G. Quack Germany
David B. Bylund United States
Aaron Janowsky United States
Henrik H. Hansen Denmark
Heinz Bönisch Germany
Jon W. Johnson United States
Jim Ropchan United States
Stephen L. Lowe relative to Edilio Borroni Switzerland Edilio Borroni's profile →
Citations per field
00.5×1.5×
Edilio Borroni · 1×
Citations per year

Countries citing papers authored by Stephen L. Lowe

Since Specialization
Citations

This map shows the geographic impact of Stephen L. Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen L. Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen L. Lowe more than expected).

Fields of papers citing papers by Stephen L. Lowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen L. Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen L. Lowe. The network helps show where Stephen L. Lowe may publish in the future.

Co-authors

The 25 scholars most cited alongside Stephen L. Lowe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen L. Lowe Line = papers co-authored together Stephen L. Lowe links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Hit paper breakdown →
2007793
2 1988152
3 1988113
4 1988112
5 198997
6 202192
7 199084
8 199681
9 201481
10 199778
11 202177
12 197074
13 198967
14 199964
15 199164
16 199460
17 200558
18 198956
19 198748
20 201534

About Stephen L. Lowe

Stephen L. Lowe is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Physiology, Cognitive Neuroscience and Pharmacology, having authored 77 papers that have together received 2.8k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (14 papers), Alzheimer's disease research and treatments (8 papers), Receptor Mechanisms and Signaling (6 papers), Protein Structure and Dynamics (5 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers), Memory and Neural Mechanisms (5 papers), Cellular transport and secretion (4 papers) and Treatment of Major Depression (4 papers). The work is most often cited by research in Biological Psychiatry (221 citations), Cellular and Molecular Neuroscience (1.2k citations), Physiology (650 citations), Psychiatry and Mental health (348 citations) and Pharmacology (378 citations). Stephen L. Lowe has collaborated with scholars based in United States, United Kingdom and Singapore. Frequent co-authors include D. M. Bowen, Paul T. Francis, Andrew Procter, Alan M. Palmer, Wanjin Hong, Siew Heng Wong, David Neary, Ferenc Martényi, Kimberley Jackson and А С Аведисова. Their work appears in journals such as Alzheimer s & Dementia, The Journal of Clinical Pharmacology, Biopolymers, Journal of Neurochemistry and British Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact